Biochips Market By Product Type, Technology, Application and by Geography - Global Trends and Forecast, 2022 - 2028

Biochip technology holds applications in areas such as diagnosis of infectious diseases, respiratory diseases, cancer, and for personalized treatment. Microarray or biochip technology could prove beneficial, as prevalence of these diseases is increasing worldwide. Complexity of the technology, necessary resources in terms of manufacturing, and research and development of these products reflects in terms of high prices. Although the product helps in reducing costs incurred in laboratory methods, the biochip technology itself is still costly. Manufacturers and universities are focused on improving technology of the biochips in order to increase the precision of the results while lowering the costs and time. For instance, researchers from Stanford University School of Medicine had developed a method to produce cheap and reusable diagnostic lab-on-a-chip with the help of an inkjet printer, which was worth 1 cent per chip, in 2017.

Market Dynamics

Miniaturization of laboratory facilities to save time and costs and extensive product portfolios with wide number of applications of biochips offered by manufacturer’s drives growth of biochips market. Manufacturers offer technologically advanced products in order to minimize time and costs, and improve research outcomes. For instance, Micralyne, Inc. launched Silicon MicraFluidics technology, a line of standardized microfluidic process technologies, which enabled rapid design and deployment of microfluidic-based products in February 2018. Technological advancements in biochips platform, ongoing research and development to widen the applications, and advantages offered by biochip technologies over conventional laboratory with respect to time, costs, and ease of use is expected to fuel growth of the market.

Key features of the study:

This report provides in-depth analysis of biochips market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global biochips market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key companies covered as a part of this study include Randox Laboratories, Fluidigm Corporation, Abbott Laboratories, Agilent Technologies, Inc., ThermoFisher Scientific, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., and PerkinElmer, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics

The global biochips market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the biochips market

Detailed Segmentation:

Global Biochips Market, By Product Type:

DNA Chips

Protein Chips

Lab-on-a-Chip

Others (Cell Arrays & Tissue Arrays)

Global Biochips Market, By Technology:

Microfluidics

Microarray

Global Biochips Market, By Application:

Genomics

Proteomics

Drug Discovery & Development

In-Vitro Diagnostics

Global Biochips Market, By Geography:

North America

By Product Type:

DNA Chips

Protein Chips

Lab-on-a-Chip

Others (Cell Arrays & Tissue Arrays)

By Technology:

Microfluidics

Microarray   

By Application:

Genomics

Proteomics

Drug Discovery & Development

In-Vitro Diagnostics

By Country:

U.S.

Canada

Europe

By Product Type:

DNA Chips

Protein Chips

Lab-on-a-Chip

Others (Cell Arrays & Tissue Arrays)

By Technology:

Microfluidics

Microarray   

By Application:

Genomics

Proteomics

Drug Discovery & Development

In-Vitro Diagnostics

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Product Type:

DNA Chips

Protein Chips

Lab-on-a-Chip

Others (Cell Arrays & Tissue Arrays)

By Technology:

Microfluidics

Microarray   

By Application:

Genomics

Proteomics

Drug Discovery & Development

In-Vitro Diagnostics

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

By Product Type:

DNA Chips

Protein Chips

Lab-on-a-Chip

Others (Cell Arrays & Tissue Arrays)

By Technology:

Microfluidics

Microarray   

By Application:

Genomics

Proteomics

Drug Discovery & Development

In-Vitro Diagnostics

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Middle East

By Product Type:

DNA Chips

Protein Chips

Lab-on-a-Chip

Others (Cell Arrays & Tissue Arrays)

By Technology:

Microfluidics

Microarray   

By Application:

Genomics

Proteomics

Drug Discovery & Development

In-Vitro Diagnostics

By Country:

GCC

Israel

Rest of Middle East

Africa

By Product Type:

DNA Chips

Protein Chips

Lab-on-a-Chip

Others (Cell Arrays & Tissue Arrays)

By Technology:

Microfluidics

Microarray   

By Application:

Genomics

Proteomics

Drug Discovery & Development

In-Vitro Diagnostics

By Country:

Central Africa

South Africa

North Africa

Company Profiles

Randox Laboratories*

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Fluidigm Corporation

Abbott Laboratories

Agilent Technologies, Inc.

ThermoFisher Scientific, Inc.

Bio-Rad Laboratories, Inc.

Illumina, Inc.

PerkinElmer, Inc.

“*” marked represents similar segmentation in other categories in the respective section.